Due to the increased risk of certain cancers (De Cock & Hyrich, 2018; Simon et al., 2019), tumor markers (CEA, CA19-9, and CA125) are diagnostic biomarkers for RA (Zheng et al., 2021). Here, CEACAM5 is linked to rheumatoid arthritis.